TGA approves booster doses of the Moderna COVID-19 vaccine, SPIKEVAX
The TGA has provisionally approved a booster dose of the Moderna COVID-19 vaccine, SPIKEVAX, for individuals 18 years and older.
- TGA provisionally approves AstraZeneca's COVID-19 vaccine as booster doseThe TGA has provisionally approved the AstraZeneca COVID-19 vaccine, Vaxzevria, for use as a booster in individuals aged 18 years and over.
- TGA Provisional Approval of Moderna COVID-19 vaccine to include 12-17 years age groupThe TGA has granted provisional approval to Moderna Australia Pty Ltd in relation to the COVID-19 vaccine, Spikevax (elasomeran), for individuals aged 12 years and over.
- TGA provisionally approves Moderna’s COVID-19 vaccine for use as a booster dose in individuals 12 years and olderOn 19 October 2022, the TGA provisionally approved Moderna's COVID-19 vaccine, SPIKEVAX (elasomeran), for use as a booster dose in individuals aged 12 years and older.